Security Snapshot

INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) Institutional Ownership

CUSIP: 457985208

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

201

Shares (Excl. Options)

74,794,840

Price

$9.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,243,257
Value change
+$4,850,908
Number of holders
201
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
77,167,269
SEC-reported price per share
$13.97
Insider filing price
$13.97
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock is tracked under CUSIP 457985208.
  • 201 institutions reported positions in Q1 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 205 to 201 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $919,385,712 to $704,695,437.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 201 institutions filings for Q1 2026.

Open SEC evidence

Security key

457985208

Latest holder period

Q1 2026

13F holders

201

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
IART
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $126,168,790 10,282,705 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 9.5% +58% $90,232,770 +$33,254,915 7,353,934 +58% Rubric Capital Management LP 30 Jun 2025
PARADIGM CAPITAL MANAGEMENT INC/NY 5.2% $39,444,821 4,012,698 PARADIGM CAPITAL MANAGEMENT INC/NY 31 Mar 2026
FULLER & THALER ASSET MANAGEMENT, INC. 4.7% $45,163,591 3,636,360 Fuller & Thaler Asset Management, Inc. 31 Dec 2025
Invesco Ltd. 4.5% -16% $50,024,712 -$8,895,949 3,490,908 -15% Invesco Ltd. 30 Sep 2025
MORGAN STANLEY 4.3% $42,546,659 3,379,401 Morgan Stanley 30 Jun 2025

As of 31 Mar 2026, 201 institutional investors reported holding 74,794,840 shares of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART). This represents 97% of the company’s total 77,167,269 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
80%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 10,319,169 -0.28% 0% $97,206,571
Rubric Capital Management LP 10% 7,753,934 0% 0.89% $73,042,058
PARADIGM CAPITAL MANAGEMENT INC/NY 5.2% 4,012,698 +51% 1.4% $37,799,615
VANGUARD PORTFOLIO MANAGEMENT LLC 4.8% 3,686,637 0% 0% $34,728,121
MORGAN STANLEY 4.6% 3,584,154 -6.9% 0% $33,762,737
FULLER & THALER ASSET MANAGEMENT, INC. 4.6% 3,529,404 -2.9% 0.11% $33,246,984
Invesco Ltd. 4.5% 3,485,603 -1.1% 0.01% $32,834,380
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 2,890,824 0% 0% $27,231,562
STATE STREET CORP 3.7% 2,886,556 +2.6% 0% $27,191,358
DIMENSIONAL FUND ADVISORS LP 3.6% 2,774,988 -10% 0.01% $26,139,617
NEUBERGER BERMAN GROUP LLC 2.7% 2,115,255 +1.8% 0.02% $19,903,884
GOLDMAN SACHS GROUP INC 2.4% 1,876,750 +31% 0% $17,678,985
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,656,985 -1.6% 0% $15,611,672
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.1% 1,612,145 +3.3% 0% $15,186,406
BANK OF AMERICA CORP /DE/ 1.8% 1,414,509 +71% 0% $13,324,674
WELLINGTON MANAGEMENT GROUP LLP 1.7% 1,300,290 -3.9% 0% $12,248,732
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.4% 1,059,286 -4.4% 0.23% $9,978,485
Invenomic Capital Management LP 1.3% 1,011,315 -4.2% 0.44% $9,526,587
GLENMEDE TRUST CO NA 1.3% 984,686 +27% 0.05% $9,275,742
Allianz Asset Management GmbH 1.2% 889,604 +37% 0.01% $8,380,070
NORTHERN TRUST CORP 0.99% 765,273 +2% 0% $7,208,872
Balyasny Asset Management L.P. 0.9% 694,076 +409% 0.01% $6,538,196
Access Investment Management LLC 0.83% 640,535 +72% 1.6% $6,033,840
MILLENNIUM MANAGEMENT LLC 0.81% 622,853 +318% 0% $5,867,275
CITADEL ADVISORS LLC 0.62% 476,701 +86% 0% $4,490,523

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 74,794,840 $704,695,437 +$4,850,908 $9.42 201
2025 Q4 73,967,449 $919,385,712 +$13,984,006 $12.42 205
2025 Q3 72,842,524 $1,043,672,317 -$4,151,749 $14.33 206
2025 Q2 73,128,875 $897,334,015 -$36,927,297 $12.27 208
2025 Q1 73,527,026 $1,616,422,067 +$95,408,342 $21.99 217
2024 Q4 69,341,057 $1,572,669,168 +$40,392,223 $22.68 221
2024 Q3 68,356,958 $1,241,956,268 -$123,869,325 $18.17 221
2024 Q2 70,995,999 $2,068,211,745 +$111,506,222 $29.14 236
2024 Q1 65,939,547 $2,336,158,778 -$70,993,946 $35.45 276
2023 Q4 66,935,797 $2,915,003,332 -$77,019,585 $43.55 283
2023 Q3 68,807,037 $2,627,769,882 -$14,108,008 $38.19 261
2023 Q2 68,833,788 $2,831,315,238 -$177,674,783 $41.13 276
2023 Q1 72,805,512 $4,179,487,921 -$119,683,717 $57.41 276
2022 Q4 74,882,267 $4,198,618,336 +$359,984,223 $56.07 274
2022 Q3 73,865,761 $3,129,594,394 +$18,803,141 $42.36 267
2022 Q2 73,142,507 $3,952,123,032 -$58,765,680 $54.03 274
2022 Q1 74,668,149 $4,798,437,509 -$193,114,447 $64.26 270
2021 Q4 77,374,227 $5,183,843,022 +$22,566,888 $66.99 266
2021 Q3 76,845,573 $5,262,770,593 +$142,772,975 $68.48 249
2021 Q2 74,753,608 $5,101,379,862 +$63,654,057 $68.24 256
2021 Q1 73,827,696 $5,100,654,311 -$19,956,840 $69.09 251
2020 Q4 74,131,946 $4,812,746,680 +$106,065,718 $64.92 242
2020 Q3 72,733,580 $3,434,003,702 +$24,582,537 $47.22 227
2020 Q2 72,219,818 $3,393,083,524 +$38,047,204 $46.99 258
2020 Q1 71,479,610 $3,192,886,669 +$34,470,345 $44.67 247
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .